$5.9 million

A minor child was admitted to the hospital for treatment of a severe asthma attack…Full Story

$5 million

For a 20-year-old former cheerleader and high achiever…Full Story

$4.809 million

A 44-year-old woman was stopped at an intersection when struck by a dump truck at 40 mph…Full Story

Learn More

• About the Firm
• Auto Accidents
• Nursing Homes
• Workers' Compensation
• Medical Malpractice
• Premises Liability
• About the Firm
• Semi-Trucks
• Community Involvement

Trasylol Linked to Kidney Failure and Death

It is among one of the more egregious examples of greed by a big pharmaceutical company ever exposed.

Bayer’s Trasylol is now off the market after an estimated 22,000 patients lost their lives after being given the drug.

Used to reduce bleeding during open heart surgery, a recent 60 Minutes report found that drug maker, Bayer AG, withheld from an FDA safety review panel, vital yet negative information about kidney failure requiring dialysis, heart attack, stroke and death among patients on Trasylol.

The FDA panel chairman said that had he known about the number of deaths from Trasylol, he would not have voted in 2006 to keep the drug on the market.

In May, 2008 results from a large Canadian clinical trial on Trasylol (aprotinin), known as BART, confirmed earlier findings. Published in the New England Journal of Medicine, it finds Trasylol led to an increase in the chance of death by 54 percent when compared to the other two, less expensive drugs commonly used during heart surgery.

In January 2006, the New England Journal of Medicine reported that more than 4,000 coronary bypass artery graft patients given Trasylol suffered twice the risk of renal (kidney) failure and stroke and had a 55 percent increase in the occurrences of heart failure or heart attack.

As many as one-third of heart surgery patients received the drug during its 14 years on the market after an aggressive, negligent and deceptive marketing campaign.

If you or a loved one experienced kidney failure after heart surgery, complications, heart attack, or stroke, you may have unknowingly received Trasylol in the hospital.

You need to contact a compassionate and knowledgeable defective drug attorney today to help evaluate your case thoroughly, before the statute of limitations runs out.

back to top

Heparin Contamination Still A Mystery

Hundreds of people have had allergic reactions and so far 81are dead from contaminated batches of the blood thinner, heparin.

Heparin, made by Baxter International, has now been recalled from the U.S. market as well as Canada, Germany, France and Japan.

The FDA launched an investigation into the Chinese manufacturing plant where the raw material for heparin is made from pigs’ intestines obtained from unregulated local cottage industries.  China is the largest supplier of raw heparin in the world.

The FDA found a contaminant in recalled vials, oversulphated condroitin sulphate, which is made from animal cartilage and is a cheaper alternative to raw heparin.

The contaminant may have been added intentionally at some point in the manufacturing process, according to the FDA which admits because of underfunding it had never inspected the Chinese facility.

Owned by Wisconsin-based Scientific Protein Laboratories, China is reportedly refusing to let the FDA inspect the plant.

Farah and Farah has been fielding calls from patients harmed by heparin and experiencing symptoms such as dizziness, difficulty breathing and nausea after heparin use.

If you or a loved one has been given the blood thinner and suffered an adverse reaction, contact our downtown Jacksonville offices.

back to top